ClinicalTrials.Veeva

Menu

Evening Primrose Oil Efficacy in Second Trimester Abortion

A

Ain Shams University

Status and phase

Unknown
Phase 3

Conditions

Missed Abortion

Treatments

Drug: Evening primrose oil(EPO)
Drug: Placebo - Cap

Study type

Interventional

Funder types

Other

Identifiers

NCT03698734
ASU obstetrics hosp

Details and patient eligibility

About

efficacy of evening primrose oil in shortening the duration of induction in 2nd trimesteric missed abortion

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primiparous women

Exclusion criteria

  • Previous uterine incision( Cs, myomectomy,)
  • Contraindications to medical or surgical uterine evacuations (eg, hemodynamically unstable, coagulopathy)
  • Evidence of intra-uterine infection
  • Rupture of fetal membranes.
  • Intrauterine device in place.
  • Allergy to prostaglandins or EPO

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Evening primrose oil
Active Comparator group
Treatment:
Drug: Evening primrose oil(EPO)
placebo
Placebo Comparator group
Treatment:
Drug: Placebo - Cap

Trial contacts and locations

1

Loading...

Central trial contact

Radwa R Ali, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems